p21CIP1 is not only a negative regulator of G1-phase cell cycle progression but also a player in determining cell terminal differentiation45, which is consistent with our finding that increased p21CIP1 expression under CC1007 treatment may contribute to pre-B-ALL cell cycle arrest and cross-lineage differentiation. The gene discussed is CDKN1A; the disease is acute lymphoblastic leukemia.